This is an unofficial archive of PsychonautWiki as of 2025-08-11T15:14:44Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.
2C-B-FLY: Difference between revisions
>Oskykins |
>Josikins m Text replacement - " | https://www.ncbi." to " (PubMed.gov / NCBI) | https://www.ncbi." |
||
| Line 18: | Line 18: | ||
==Pharmacology== | ==Pharmacology== | ||
{{Main|Serotonergic psychedelic}} | {{Main|Serotonergic psychedelic}} | ||
2C-B-FLY's [[psychedelic]] effects are believed to come from its efficacy at the [[Serotonin#The 5-HT system|5-HT<sub>2A</sub> receptor]] as a [[Agonist#Agonists|partial agonist]]. It also has a high binding affinity for the 5-HT<sub>1D</sub>, 5-HT<sub>1E</sub>, 5-HT<sub>1A</sub>, 5-HT<sub>2B</sub> and 5-HT<sub>2C</sub> receptors.<ref>Psychedelics and the human receptorome. | https://www.ncbi.nlm.nih.gov/pubmed/20126400</ref> | 2C-B-FLY's [[psychedelic]] effects are believed to come from its efficacy at the [[Serotonin#The 5-HT system|5-HT<sub>2A</sub> receptor]] as a [[Agonist#Agonists|partial agonist]]. It also has a high binding affinity for the 5-HT<sub>1D</sub>, 5-HT<sub>1E</sub>, 5-HT<sub>1A</sub>, 5-HT<sub>2B</sub> and 5-HT<sub>2C</sub> receptors.<ref>Psychedelics and the human receptorome. (PubMed.gov / NCBI) | https://www.ncbi.nlm.nih.gov/pubmed/20126400</ref> | ||
However, the role of these interactions and how they result in the [[psychedelic]] experience continues to remain elusive. | However, the role of these interactions and how they result in the [[psychedelic]] experience continues to remain elusive. | ||